Strong 1H18 Result and New Products Expected to Support Future Growth
CSL Ltd (CSL AU) reported their 1H18 result on 14 February 2018: Revenue $4,147m, up 11% at constant currency (cc) EBIT $1,476m, up 31% cc NPAT...
191 Views
Aussie Equities Model Portfolio Update
Australia is in a sweet spot. We are sticking to the themes and sector positioning outlined in our 2018 outlook. We still think the ASX200 will...
226 Views
Sanofi: Stop the Bleeding with Bioverativ
Today, Sanofi (SAN FP) announced that it is acquiring Bioverativ Inc (BIVV US) for $11.6 billion (a 64% premium). Management hosted a conference...
376 Views
Aussie Healthcare Daily: 12 & 13 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
492 Views
Putting Aussie Earnings Under the Microscope
It's not too late to jump on board the Growth train. One of our key calls for 2018 is that Growth will again outperform Value (Aussie Equities...
239 Views